Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-02-05
DOI
10.1038/srep20617
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
- (2016) Katie Ewer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Understanding Rift Valley fever: Contributions of animal models to disease characterization and control
- (2015) Gema Lorenzo et al. MOLECULAR IMMUNOLOGY
- Ebola teaches tough lessons about rapid research
- (2015) Erika Check Hayden NATURE
- Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults
- (2015) Christopher A. Green et al. Science Translational Medicine
- One Health approach to Rift Valley fever vaccine development
- (2014) Jeroen Kortekaas ANTIVIRAL RESEARCH
- A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
- (2014) L. Swadling et al. Science Translational Medicine
- Development of a Rift Valley fever virus viremia challenge model in sheep and goats
- (2014) Hana M. Weingartl et al. VACCINE
- A Glycoprotein Subunit Vaccine Elicits a Strong Rift Valley Fever Virus Neutralizing Antibody Response in Sheep
- (2014) Bonto Faburay et al. VECTOR-BORNE AND ZOONOTIC DISEASES
- Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
- (2013) Richard D Antrobus et al. MOLECULAR THERAPY
- Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1
- (2013) Nicola Borthwick et al. MOLECULAR THERAPY
- Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
- (2013) George M Warimwe et al. Virology Journal
- Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
- (2013) Katie J. Ewer et al. Nature Communications
- A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
- (2012) Matthew D. J. Dicks et al. PLoS One
- Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
- (2012) S. Colloca et al. Science Translational Medicine
- Breaking the chain: Rift Valley fever virus control via livestock vaccination
- (2012) Brian H Bird et al. Current Opinion in Virology
- Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study
- (2011) Janice M. Rusnak et al. VACCINE
- Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves
- (2011) Beate von Teichman et al. VACCINE
- Rift Valley Fever Virus Epidemic in Kenya, 2006/2007: The Entomologic Investigations
- (2010) Rosemary Sang et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Epidemiologic and Clinical Aspects of a Rift Valley Fever Outbreak in Humans in Tanzania, 2007
- (2010) Mohamed Mohamed et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep
- (2010) Baptiste Dungu et al. VACCINE
- Experimental Infection of Young Adult European Breed Sheep with Rift Valley Fever Virus Field Isolates
- (2010) Nuria Busquets et al. VECTOR-BORNE AND ZOONOTIC DISEASES
- Prediction of a Rift Valley fever outbreak
- (2009) Assaf Anyamba et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Global trends in emerging infectious diseases
- (2008) Kate E. Jones et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started